Anthropic Secondary Market Heats Up Amid Fraud Concerns
Global Markets Dip as Middle East Tensions Fuel Oil Price Surge US Growth Revised Downward
SGX RegCo Proposes ThreeYear Deadline for Suspended Firms to Resume Trading or Face Delisting
Retail Sales Defy Consumer Pessimism How Long Can the Paradox Last
Indian Commerce Department Gathers Industry Input on NonTariff Barriers Ahead of US Trade Team Visit
Pokmon Card Market Boom Nostalgia Speculation and Celebrity Involvement Drive HighValue Sales
United Community Banks Inc UCB Q1 2026 Earnings Earnings Miss Expectations Despite Solid Profitability
VNT Q1 2026 Earnings EPS Falls Short of Estimates Shares Slip
RPAY Q1 2026 Earnings EPS Beat Drives Positive Market Reaction
Cyclerion Therapeutics CYCN Q4 2025 Earnings Narrower Loss Surprises Analysts
Airgain Inc AIRG Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction
PEW Q1 2026 Earnings EPS Beat Drives Optimism Despite Revenue Uncertainty and Stock Dip
FGBIP Preferred Stock Holds Steady at 2049 as Yield Attracts Income Seekers
Cheniere Energy Partners CQP Holds Steady Near 61 Showing Resilience in Quiet Trading
Atlanticus Holdings Senior Notes ATLCL Hold Steady at 2515 Amidst Stable Yield Considerations
AEye Inc LIDR Gains 37 as Shares Approach Key Resistance
BankUnited BKU Gains 214 Regional Bank Strength Tests Key Resistance Zone
US Productivity Growth Moderates in Q4 as Labor Costs Rise Implications for Inflation and Fed Policy
CATO Q4 2025 Earnings Reported Loss of 055 Per Share Shares Decline 64
Moolec Science MLEC Slides 44 Amid Selling Pressure Key Support at 706 in Focus
Cinemark Holdings CNK Posts Modest Gain as Stock Approaches Key Resistance
Compugen Surges 7 as Biotech Stock Tests Key Resistance Levels CGEN
Cohen Steers LDP Holds Steady Near Support Amid Preferred Income Stability
High Roller Technologies ROLR Slips 236 as Stock Tests Key Support Near 512
LPL Financial Holdings LPLA Slides 48 as Broader Market Pressure Weighs on Financials
Precision Drilling PDS Drops 324 as Weakness Tests Support at 8524
Avalo Therapeutics AVTX Slips 15 as Stock Consolidates Between Key Support and Resistance